N°66 - Évènement /Nutriform Business Days 2018 The regulation investor can be a means of support in the conso- manufacturing practices”. Elements that seem was also lidation of a sector extremely fragmented such as to be lacking for now. discussed the one of food supplements. This does not prevent the companies from The second pillar: the R&D carried out by a seeking growth outlets beyond the domestic • Youssef El Ouadrhiri, company. In particular, the start-ups Gynov and market, even in the broader sense of the term biochemistry and (meaning Europe). The European brands enter food technology Indigo therapeutics, companies specializing in engineer, coordinator the development of food supplements, foods for the Chinese market via platforms specialized in of the working group special medical purposes and medical devices SME search. This is the case of Arkopharma, “Plantes” and of the “Human Nutrition” targeting the health of women as regards the fi rst which, at the end of 2017, entered a partnership Board of Specialized one, clinical nutrition and the modulation of the with Kaola, a NetEasy subsidiary specializing Experts within ANSES, was there to gut microbiota as regards the second. These two in cross-border retail e-commerce deploying present the missions companies were created by Pierre-Yves Mousset. a selective approach exclusively dedicated to of the working group The core principle of these two companies is that foreign products. Stéphanie Peigné, Head of “Plantes”. What are the consequences? certain food ingredients are likely to provide under- Insight & Innovation at Arkopharma Global Mar- What are the steps exploited health benefi ts. Such an example is the keting, presented this approach and how the to follow in order to comply with the development of Renoral, the fi rst ready-to-use,® group is adapting its formulas to penetrate the regulation? In one high-protein supplement specifi cally formulated export markets. word, will it simplify ® the registration to offset the intradialytic amino acid loss. Renoral Undeniably, when affi xed on a pack, the“Made procedures? stands out through the quality of its native proteins in France” label is a serious asset for interna- • Thomas Pauquai, with high levels of essential amino acids (43%). tional growth. These aspects were presented head of the Health Last but not least, university innovation can be by Marie-Pascal Legrand, General Manager of Claims and Food turned into business. Yalacta and former Vice-Chairperson of SYNA- Safety Department at DIET (she participated in drafting the Quality Nutraveris, focused on the consequences The perfect example is InflamLab, a company Charter for Food Supplements), who this time of the new Novel created in 2016 and working in close collaboration presented herself as a Foreign Trade Advisor for Food regulation, 128 applicable as of 1 with UMR 152 (Inserm Unit), which develops in France and member of the Commission for Busi- January 2018. vivo and in vitromodels to study the role of macro- ness Support and of the Teaching Commission. • Amy Mozingo, phages in the resolution of infl ammation (Editor’s She delivered her feedback as a manager of a consultant at RNI note: macrophages are the fi rst line of defence in very small company and presented the “Made Consulting US, different physiopathological situations). The purpose in France” label, which relies on the observance travelled from Florida to unveil the different of these models is to evaluate the effi cacy of active of a number of legal obligations and customs mechanisms ingredients that can “redirect the phenotypes of defi nitions. Just for the record, an implemen- and routes food ingredients can take - macrophage towards repairing phenotypes,” accor- ting regulation as regards the rules for indica- whether Novel foods ding to Bernard Pipy, Emeritus Research Director at ting the country of origin has been published at or not. Inserm, founder and CEO of Infl amLab. In the end, European level and it also concerns the Made the objective of research is to understand whether in France indication. SYNADIET is setting up a the infl ammatory pathologies, particularly within working group regarding this subject. metabolic diseases and ageing-related (low-level “We estimate that the French companies in infl ammation), are due to a defect in the resolution of the food supplement sector could achieve infl ammation and the polarization of macrophages 30%of their turnover abroad - that is €600 towards a proresolution phenotype. million,” said Christèle Chapteuil, Chairperson of SYNADIET and General Manager of Juva (Edi- Exports: exploring new territories. tor’s note: for the time being, exports are worth only €150 million, which is about 10% of the Exports are a means to conquer the global French market). A growth achieved “thanks to market for food supplements, which is estimated the attractiveness of the Made in France indi- at nearly $120 billion - about 10 times more than cation and thanks to the market players’ exper- the European market or, to be more explicit, tise”. But in order to achieve that, it is necessary almost 70 times more than the French market. to overcome certain barriers to exporting and to Exporting means that it is necessary to comply improve certain tools. Christèle Chapteuil deli- with regulatory constraints that may be drastic vered a general overview of the export practices and fl uctuating like in countries such as China and certifi cations. Which was quite enough to or Brazil. Exporting means being able to provide encourage the beginners in this area to consider the national authorities with certifi cates of “good the future with optimism… ■ ■ / Janvier - Février - Mars 2019 / N°66 / L’Actualité des Ingrédients Fonctionnels & Santé